Stevanato Group S.p.A (STVN) Income from Non-Controlling Interests (2020 - 2026)
Stevanato Group S.p.A (STVN) reported Income from Non-Controlling Interests of -$2341.5 for Q1 2026, up 25.8% year-over-year from -$1861.3 in Q1 2025, and up 32.95% quarter-over-quarter from -$3492.1 in Q4 2025.
Stevanato Group S.p.A (STVN) Income from Non-Controlling Interests (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has 7 years of Income from Non-Controlling Interests data on file, last reported at -$2341.5 in Q1 2026.
- Income from Non-Controlling Interests for Q1 2026 came in at -$2341.5, up 25.8% year-over-year; the trailing twelve-month figure through Mar 2026 was -$12195.1 (up 12.93% YoY), and the FY2025 annual result was $44233.7, up 444.95% from the prior year.
- Income from Non-Controlling Interests grew to -$2341.5 in Q1 2026 per STVN's latest filing, from -$3492.1 in the prior quarter.
- Over five years, Income from Non-Controlling Interests peaked at $99236.3 in Q2 2022 and troughed at -$39789.6 in Q4 2022.
- A 5-year average of $18623.0 and a median of -$1088.6 in 2023 frame the typical range for Income from Non-Controlling Interests.
- The sharpest annual moves came in 2024 and 2025: Income from Non-Controlling Interests plunged 404.42% in 2024, then soared 2359.95% in 2025.
- A 5-year view of Income from Non-Controlling Interests shows it stood at -$39789.6 in 2022, then surged by 105.41% to $2151.9 in 2023, then tumbled by 248.98% to -$3205.8 in 2024, then fell by 8.93% to -$3492.1 in 2025, then soared by 32.95% to -$2341.5 in 2026.
- Business Quant data shows STVN's Income from Non-Controlling Interests at -$2341.5 in Q1 2026, -$3492.1 in Q4 2025, and $47931.3 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 5.00 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | - |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 105.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | - |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | - |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | - |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | - |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | - |
| 10 | Stevanato Group S.p.A | 433.37 Mn | 290.42 Mn | 88.01 Mn | -2,341.49 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,341.49 |
| Dec 31, 2025 | -3,492.13 |
| Sep 30, 2025 | 47,931.26 |
| Jun 30, 2025 | 48,674.27 |
| Mar 31, 2025 | -3,155.65 |
| Dec 31, 2024 | -3,205.79 |
| Sep 30, 2024 | -5,491.10 |
| Jun 30, 2024 | -2,153.78 |
| Mar 31, 2024 | -2,172.72 |
| Dec 31, 2023 | 2,151.88 |
| Sep 30, 2023 | -1,088.59 |
| Jun 30, 2023 | 43,556.98 |
| Mar 31, 2023 | 19,320.15 |
| Dec 31, 2022 | -39,789.65 |
| Sep 30, 2022 | 72,595.75 |
| Jun 30, 2022 | 99,236.27 |
| Mar 31, 2022 | 46,015.85 |
| Dec 31, 2021 | -82,365.91 |
| Sep 30, 2021 | -22,406.46 |
| Jun 30, 2021 | 30,106.79 |